Developments in restenosis

被引：4

作者：

Chan, A ^{[1
]}

机构：

[1] No Gen Hosp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England

来源：

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 2002年 / 3卷 / 03期

关键词：

restenosis; clinical trials; angiotensin; vascular smooth muscle;

D O I：

10.3317/jraas.2002.033

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Restenosis is a major complication leading to the failure of vascular procedures, including surgery, angioplasty and stenting. Major efforts including over 100 clinical trials have been made to overcome this complication, with little success to date. Issues relating to trial rationale, design, measurement and biology are addressed in this review.

引用

页码：145 / 149

页数：5

共 27 条

[1]

Amant C, 1997, CIRCULATION, V96, P56

[2]

BALCON R, 1992, CIRCULATION, V86, P100

[3] RESTENOSIS AFTER CORONARY ANGIOPLASTY - NEW STANDARDS FOR CLINICAL-STUDIES [J].

BEATT, KJ ;

SERRUYS, PW ;

HUGENHOLTZ, PG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (02) :491-498

[4] Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries - Results from the multicenter American research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR) [J].

Berger, PB ;

Holmes, DR ;

Ohman, EM ;

OHanesian, MA ;

Murphy, JG ;

Schwartz, RS ;

Serruys, PW ;

Faxon, DP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (01) :1-7

[5] ABNORMAL GROWTH-REGULATION OF VASCULAR SMOOTH-MUSCLE CELLS BY HEPARIN IN PATIENTS WITH RESTENOSIS [J].

CHAN, P ;

PATEL, M ;

BETTERIDGE, L ;

MUNRO, E ;

SCHACHTER, M ;

WOLFE, J ;

SEVER, P .

LANCET, 1993, 341 (8841) :341-342

[6] LONG-TERM EFFECTS OF ANGIOPEPTIN TREATMENT IN CORONARY ANGIOPLASTY - REDUCTION OF CLINICAL EVENTS BUT NOT ANGIOGRAPHIC RESTENOSIS [J].

EMANUELSSON, H ;

BEATT, KJ ;

BAGGER, JP ;

BALCON, R ;

HEIKKILA, J ;

PIESSENS, J ;

SCHAEFFER, M ;

SURYAPRANATA, H ;

FOEGH, M .

CIRCULATION, 1995, 91 (06) :1689-1696

[7] A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].

FISCHMAN, DL ;

LEON, MB ;

BAIM, DS ;

SCHATZ, RA ;

SAVAGE, MP ;

PENN, I ;

DETRE, K ;

VELTRI, L ;

RICCI, D ;

NOBUYOSHI, M ;

CLEMAN, M ;

HEUSER, R ;

ALMOND, D ;

TEIRSTEIN, PS ;

FISH, RD ;

COLOMBO, A ;

BRINKER, J ;

MOSES, J ;

SHAKNOVICH, A ;

HIRSHFELD, J ;

BAILEY, S ;

ELLIS, S ;

RAKE, R ;

GOLDBERG, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501

[8] Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty [J].

Hamon, M ;

Amant, C ;

Bauters, C ;

Richard, F ;

Helbecque, N ;

Passard, F ;

McFadden, EP ;

Lablanche, JM ;

Bertrand, ME ;

Amouyel, P .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01) :79-+

[9]

Keegan John., 1999, The First World War

[10] Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement [J].

Koch, W ;

Kastrati, A ;

Mehilli, J ;

Böttiger, C ;

von Beckerath, N ;

Schömig, A .

CIRCULATION, 2000, 102 (02) :197-202

← 1 2 3 →